Clinical trials
Phase 3 Anemia trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 5 |
| GlaxoSmithKline | 4 |
| Tanabe Pharma Corporation | 4 |
| Celgene | 3 |
| Astellas Pharma Inc | 2 |
| Kissei Pharmaceutical Co., Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
| Takeda | 2 |
| Amgen | 1 |
| Chugai Pharmaceutical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 28 |
| Renal Insufficiency, Chronic | 10 |
| Myelodysplastic Syndromes | 3 |
| Primary Myelofibrosis | 3 |
| Hemoglobinuria, Paroxysmal | 2 |
| Neoplasms | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blood Platelet Disorders | 1 |
| Bone Marrow Diseases | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.